Abnormalities in the expression of a cell cycle regulatory protein such as CCND1 due to genomic inversions, translocation and gene amplification have been identified as a cause for poor prognosis and drug resistance in HNSCC. The gene discussed is CCND1; the disease is head and neck squamous cell carcinoma.